Presentation is loading. Please wait.

Presentation is loading. Please wait.

National data in surgery: LCCOP 2018(2016)

Published byYanti Yuwono Modified over 5 years ago

Similar presentations

Presentation on theme: "National data in surgery: LCCOP 2018(2016)"— Presentation transcript:

1 National data in surgery: LCCOP 2018(2016)
Doug West Audit Committee Chair, Society for Cardiothoracic Surgery National data in surgery: LCCOP 2018(2016)

2 lung cancer England 2016

3 Metrics 2018 30 day survival* 90 day survival* 365 day survival*
Median length of stay Resection rate 90 day all cause all site NHS readmission Unit and individual surgeon volume lung cancer England 2016

4 Rising activity

5

6 Pneumonectomy and survival

7 lung cancer England 2016

8 lung cancer England 2016

9

10

11 Unadjusted correlation: median LOS and 90 day all cause readmission (HES)
Corr coeff

12

13 lung cancer England 2016

Download ppt "National data in surgery: LCCOP 2018(2016)"

Similar presentations

How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.

How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.
Norwegian register for general thoracic surgery.

Norwegian register for general thoracic surgery.
How clinicians use data to make an impact on clinical outcomes

How clinicians use data to make an impact on clinical outcomes
A Hussain, S Qadri, Y Haqzad, M Chaudhry, A Cale, M Cowen, M Loubani.

A Hussain, S Qadri, Y Haqzad, M Chaudhry, A Cale, M Cowen, M Loubani.
Curative treatment rates for patients diagnosed with

Curative treatment rates for patients diagnosed with
National Bowel Cancer Audit

National Bowel Cancer Audit
National data in thoracic surgery

National data in thoracic surgery
Table 1 Baseline patient characteristics

Table 1 Baseline patient characteristics
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Functional Recovery in the Elderly After Major Surgery: Assessment of Mobility Recovery Using Wireless Technology  David J. Cook, MD, Jeffrey E. Thompson,

Functional Recovery in the Elderly After Major Surgery: Assessment of Mobility Recovery Using Wireless Technology  David J. Cook, MD, Jeffrey E. Thompson,
Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R

Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R
Thoracic audit update SCTS Board of Representatives

Thoracic audit update SCTS Board of Representatives
A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,

Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,
Surgical update.

Surgical update.

Similar presentations

Ads by Google